作者
Pelagia G Tsoutsou, Michael I Koukourakis, David Azria, Yazid Belkacémi
发表日期
2009/8/1
来源
Critical reviews in oncology/hematology
卷号
71
期号
2
页码范围
102-116
出版商
Elsevier
简介
PURPOSE
The optimal sequence of modalities involved in breast cancer treatment with respect to radiotherapy and the maximum acceptable interval between radiotherapy and surgery need to be determined.
DESIGN
This review attempts a critical reading of the literature.
RESULTS
A delay of radiotherapy more than 8–12 weeks after surgery adversely affects local recurrence. Radiotherapy should be administered within 7 months after surgery, when chemotherapy is administered first. Several chemotherapy regimens can be safely administered concurrently with radiotherapy. The concurrent use of tamoxifen with chemotherapy should be avoided, but not with radiotherapy. Data is insufficient with regard to concurrent use of aromatase inhibitors with radiotherapy. The use of trastuzumab concomitantly with radiotherapy may enhance toxicities but may also improve its efficacy.
CONCLUSIONS
Although the issue of …
引用总数
201020112012201320142015201620172018201920202021202220232024112322474581189114
学术搜索中的文章
PG Tsoutsou, MI Koukourakis, D Azria, Y Belkacémi - Critical reviews in oncology/hematology, 2009